|
|
|
| Webinar: Fulfilling the Promise of Advanced Therapies and a Noble Cause | Join Vector BioMed for a webinar highlighting how collaboration and innovation are transforming access to cell and gene therapies. Learn how VBM and Muni Seva Ashram are expanding affordable CGT to underserved communities through scalable, patient-forward solutions. Discover how LENTIVERSE™ addresses global challenges in vector manufacturing, access, and speed-to-patient—proving that equitable, high-quality care is possible worldwide. Click here to learn more. |
|
|
|
|
By Shubhranshu Gupta, Ph.D., cell therapy expert | The second part of a discussion on closed-loop systems explores the CDMO and equipment landscape for scaling automated closed loop cell therapy manufacturing systems. | |
|
|
|
|
|
| Working With An End-To-End CDMO To De-Risk AAV Production | Article | By Artur Padzik, Ph.D., 3PBIOVIAN | Consider how the following strategies can be used to optimize AAV manufacturing by reducing risk and balancing productivity, quality, and cost to meet the growing demands of gene therapy. |
|
|
|
|
|
|
|
|
| Explore the evolving role of exosomes and extracellular vesicles (EVs) at the next Cell & Gene Live. Chief Editor Erin Harris moderates a discussion with Capricor’s Linda Marbán and Aegle’s Dr. Gloria Matthews on clinical and commercial advances, including applications in rare and cardiovascular diseases. Gain insights into the future of exosome-based therapies from leaders driving innovation across R&D, manufacturing, and commercialization. |
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
